Oric Pharmaceuticals, Inc.·4

Jun 14, 4:26 PM ET

You Angie 4

4 · Oric Pharmaceuticals, Inc. · Filed Jun 14, 2024

Insider Transaction Report

Form 4
Period: 2024-06-12
You Angie
Director
Transactions
  • Award

    Stock Option (right to buy)

    2024-06-12+25,60025,600 total
    Exercise: $7.90Exp: 2034-06-11Common Stock (25,600 underlying)
Footnotes (1)
  • [F1]One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) June 12, 2025 or (ii) the business day prior to the next annual meeting of the Issuer's stockholders that occurs following the date of grant.

Documents

1 file
  • 4
    form4-06142024_080646.xmlPrimary